Novel perspectives on the hepatitis B virus vaccine in the chronic kidney disease population.
CONCLUSIONS: The immunogenicity of HBV vaccines in patients with CKD is suboptimal but novel technologies promise to give better results in the near future.
PMID: 26821784 [PubMed - as supplied by publisher]
Source: The International Journal of Artificial Organs - Category: Transplant Surgery Authors: Fabrizi F, Martin P, Messa P Tags: Int J Artif Organs Source Type: research
More News: Chronic Kidney Disease | Dialysis | Hepatitis | Hepatitis B | Hepatitis Vaccine | Kidney Transplant | Transplant Surgery | Urology & Nephrology | Vaccines